190 related articles for article (PubMed ID: 31488259)
1. Autoimmune haemolytic anaemias: A retrospective study of 93 patients.
Gutiérrez Jomarrón I; López Rubio M; Morado Arias M; Arrizabalaga B; de la Iglesia S; Beneitez D; Sáez MI; Cervera A; Recasens V; Herrera A; Villegas AM;
Med Clin (Barc); 2020 May; 154(9):331-337. PubMed ID: 31488259
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune haemolytic anaemia.
Argüello Marina M; López Rubio M; Castilla García L
Med Clin (Barc); 2023 Jan; 160(1):30-38. PubMed ID: 36334945
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.
Valent P; Lechner K
Wien Klin Wochenschr; 2008; 120(5-6):136-51. PubMed ID: 18365153
[TBL] [Abstract][Full Text] [Related]
4. Rituximab in the treatment of autoimmune haemolytic anaemia.
Rodrigo C; Rajapakse S; Gooneratne L
Br J Clin Pharmacol; 2015 May; 79(5):709-19. PubMed ID: 25139610
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies.
Reynaud Q; Durieu I; Dutertre M; Ledochowski S; Durupt S; Michallet AS; Vital-Durand D; Lega JC
Autoimmun Rev; 2015 Apr; 14(4):304-13. PubMed ID: 25497766
[TBL] [Abstract][Full Text] [Related]
6. A case of autoimmune haemolytic anaemia achieving complete response with rituximab.
Dev M; Mushtaq N; Faisal A
J Pak Med Assoc; 2014 Jun; 64(6):700-2. PubMed ID: 25252495
[TBL] [Abstract][Full Text] [Related]
7. Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia.
Heidel F; Lipka DB; von Auer C; Huber C; Scharrer I; Hess G
Thromb Haemost; 2007 Feb; 97(2):228-33. PubMed ID: 17264951
[TBL] [Abstract][Full Text] [Related]
8. [Cold agglutinin disease - no response to glucocorticoids and rituximab, what treatment is best for the 3rd line of therapy? Case report and review of the literature].
Adam Z; Pejchalová A; Chlupová G; Ríhová L; Pour L; Krejčí M; Cervinek L; Král Z; Mayer J
Vnitr Lek; 2013 Sep; 59(9):828-40. PubMed ID: 24073955
[TBL] [Abstract][Full Text] [Related]
9. [Are intravenous immunoglobulins useful in severe episodes of autoimmune hemolytic anemia?: Comparative results in 21 episodes from a single centre].
Gil-Fernández JJ; Flores Ballester E; González Martínez M; Arévalo-Serrano J; Tamayo Martín AT; Burgaleta Alonso de Ozalla C
Med Clin (Barc); 2013 Sep; 141(5):201-4. PubMed ID: 22857805
[TBL] [Abstract][Full Text] [Related]
10. [Autoimmune haemolytic anaemia: a review and report of four cases].
Nyilas R; Székely B; Váróczy L; Simon Z; Árokszállási A; Illés Á; Gergely L
Orv Hetil; 2015 Mar; 156(11):449-56. PubMed ID: 25749539
[TBL] [Abstract][Full Text] [Related]
11. Disease-modifying treatments for primary autoimmune haemolytic anaemia.
Liu AP; Cheuk DK
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012493. PubMed ID: 33786812
[TBL] [Abstract][Full Text] [Related]
12. Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma.
Win N; Tiwari D; Keevil VL; Needs M; Lakhani A
Hematology; 2007 Apr; 12(2):159-62. PubMed ID: 17454198
[TBL] [Abstract][Full Text] [Related]
13. [Rituximab instead of splenectomy in 4 children with chronic or refractory autoimmune haemolytic anaemia].
van Daalen ST; van Dijken PJ; Tamminga RY; Brons PP
Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2350-4. PubMed ID: 16261716
[TBL] [Abstract][Full Text] [Related]
14. A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia.
Maung SW; Leahy M; O'Leary HM; Khan I; Cahill MR; Gilligan O; Murphy P; McPherson S; Jackson F; Ryan M; Hennessy B; McHugh J; Goodyer M; Bacon L; O'Gorman P; Nee A; O'Dwyer M; Enright H; Saunders J; O'Keeffe D
Br J Haematol; 2013 Oct; 163(1):118-22. PubMed ID: 23909468
[TBL] [Abstract][Full Text] [Related]
15. Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study.
Ducassou S; Leverger G; Fernandes H; Chambost H; Bertrand Y; Armari-Alla C; Nelken B; Monpoux F; Guitton C; Leblanc T; Fisher A; Lejars O; Jeziorski E; Fouissac F; Lutz P; Pasquet M; Pellier I; Piguet C; Vic P; Bayart S; Marie-Cardine A; Michel M; Perel Y; Aladjidi N
Br J Haematol; 2017 Jun; 177(5):751-758. PubMed ID: 28444729
[TBL] [Abstract][Full Text] [Related]
16. [Autoimmune hemolytic anemia: Case review].
Sánchez N; Zubicaray J; Sebastián E; Gálvez E; Sevilla J
An Pediatr (Engl Ed); 2021 Apr; 94(4):206-212. PubMed ID: 32972857
[TBL] [Abstract][Full Text] [Related]
17. Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA.
Laribi K; Bolle D; Ghnaya H; Sandu A; Besançon A; Denizon N; Truong C; Pineau-Vincent F; de Materre AB
Ann Hematol; 2016 Apr; 95(5):765-9. PubMed ID: 26858026
[TBL] [Abstract][Full Text] [Related]
18. Treatment of childhood autoimmune haemolytic anaemia with rituximab.
Quartier P; Brethon B; Philippet P; Landman-Parker J; Le Deist F; Fischer A
Lancet; 2001 Nov; 358(9292):1511-3. PubMed ID: 11705566
[TBL] [Abstract][Full Text] [Related]
19. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
20. The role of rituximab in adults with warm antibody autoimmune hemolytic anemia.
Dierickx D; Kentos A; Delannoy A
Blood; 2015 May; 125(21):3223-9. PubMed ID: 25827833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]